OpenAI Rolls Out ChatGPT Health, Claims Clinician-Level AI
Get the Tech newsletter
Daily tech — startups, AI labs, chips, the launches that shape the next decade. Free.
- OpenAI is rolling out ChatGPT Health to all logged-in US users aged 18+ on web and iOS, across free, Go, Plus, and Pro plans, after a limited earlier release.
- Ashley Alexander, OpenAI's VP of health product, claimed the company's models 'are now capable of reasoning at levels that are better than clinician level.'
- OpenAI health lead Karan Singhal tempered the claim in the same briefing, pointing to unspecified 'individual studies' from Harvard and Stanford rather than offering a specific benchmark.
- A Florida pastor sued OpenAI on Wednesday, alleging ChatGPT gave him 'extremely dangerous medical recommendations' that led him to delay care for a pulmonary embolism.
- The broader release follows OpenAI's launch of GPT-5.6 Sol, which the company calls its 'strongest model yet for health' and which ChatGPT Health will run on.
- Users can now ask questions about connected medical data directly in the main chat, with data types including post-visit notes, lab results, and medications, sourced from providers and apps including Apple Health, Weight Watchers, MyFitnessPal, and Function.
- OpenAI says conversations are 'encrypted at rest and at transit,' with health-connected information receiving additional encryption, and that ChatGPT Health 'supports, not replaces, professional care.'
Why it matters: OpenAI is putting ChatGPT in direct contact with real medical records while publicly branding its AI as outperforming clinicians — a claim the company's own health lead softened on the same call. With a lawsuit alleging ChatGPT advice caused a patient to delay treatment for a pulmonary embolism, OpenAI is expanding health features and clinical-level ambitions simultaneously, before any external validation of that capability.
